Brickell Biotech Inc - ESG Rating & Company Profile powered by AI
The assessment of Brickell Biotech Inc leverages information from across the web and also from public disclosures by Brickell Biotech Inc. The webpage includes a questions and answers section on Brickell Biotech Inc. Alternative companies in the rating peer group for Brickell Biotech Inc are displayedin the table.
Brickell Biotech Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.4; made up of an environmental score of 2.7, social score of 1.6 and governance score of 6.0.
3.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1186 | Simply Better Brands Corp | 3.5 | Medium |
| 1186 | Yunnan Baiyao Group Co Ltd | 3.5 | Medium |
| 1234 | Brickell Biotech Inc | 3.4 | Medium |
| 1234 | Cassava Sciences Inc | 3.4 | Medium |
| 1234 | Ardelyx Inc | 3.4 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Brickell Biotech Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Brickell Biotech Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Brickell Biotech Inc report the average age of the workforce?
Sign up for free to unlockDoes Brickell Biotech Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Brickell Biotech Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Brickell Biotech Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Brickell Biotech Inc offer flexible work?
Sign up for free to unlockDoes Brickell Biotech Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Brickell Biotech Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Brickell Biotech Inc conduct supply chain audits?
Sign up for free to unlockDoes Brickell Biotech Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Brickell Biotech Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Brickell Biotech Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Brickell Biotech Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Brickell Biotech Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Brickell Biotech Inc disclose water use targets?
Sign up for free to unlockDoes Brickell Biotech Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Brickell Biotech Inc have a product recall in the last two years?
Sign up for free to unlockDoes Brickell Biotech Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Brickell Biotech Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Brickell Biotech Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Brickell Biotech Inc disclose parental leave metrics?
Sign up for free to unlockDoes Brickell Biotech Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Brickell Biotech Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Brickell Biotech Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Brickell Biotech Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Brickell Biotech Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Brickell Biotech Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Brickell Biotech Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Brickell Biotech Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Brickell Biotech Inc disclose its waste policy?
Sign up for free to unlockDoes Brickell Biotech Inc report according to TCFD requirements?
Sign up for free to unlockDoes Brickell Biotech Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Brickell Biotech Inc disclose energy use targets?
Sign up for free to unlockDoes Brickell Biotech Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Brickell Biotech Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Brickell Biotech Inc
These potential risks are based on the size, segment and geographies of the company.
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.